Schroder Investment Management Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-139,976
Closed -$4.1M 1207
2024
Q3
$4.1M Buy
139,976
+27,810
+25% +$717K ﹤0.01% 823
2024
Q2
$2.14M Sell
112,166
-810
-0.7% -$20.7K ﹤0.01% 920
2024
Q1
$3.7M Sell
112,976
-27,345
-19% -$873K ﹤0.01% 832
2023
Q4
$4.63M Buy
+140,321
New +$3.97M 0.01% 781
2019
Q4
Sell
-33,212
Closed -$241K 1301
2019
Q3
$241K Buy
33,212
+4,642
+16% +$33.3K ﹤0.01% 1136
2019
Q2
$227K Sell
28,570
-28,707
-50% -$340K ﹤0.01% 1071
2019
Q1
$721K Hold
57,277
﹤0.01% 961
2018
Q4
$1.14K Sell
57,277
-19,149
-25% -$443K ﹤0.01% 852
2018
Q3
$2.17M Hold
76,426
﹤0.01% 808
2018
Q2
$1.67M Buy
76,426
+21,925
+40% +$415K ﹤0.01% 853
2018
Q1
$777K Hold
54,501
﹤0.01% 995
2017
Q4
$670K Hold
54,501
﹤0.01% 1052
2017
Q3
$995K Sell
54,501
-16,385
-23% -$338K ﹤0.01% 975
2017
Q2
$1.79M Hold
70,886
﹤0.01% 884
2017
Q1
$1.53M Buy
+70,886
New +$1.36M ﹤0.01% 892
2016
Q1
Sell
-355,922
Closed -$4.31M 1168
2015
Q4
$4.31M Buy
355,922
+194,222
+120% +$2.86M 0.01% 776
2015
Q3
$2.58M Sell
161,700
-38,300
-19% -$747K 0.01% 824
2015
Q2
$3.9M Buy
+200,000
New +$3.73M 0.01% 765

Other funds holding EVH

Schroder Investment Management Group's EVH Position: Q4 2024 in Review

Schroder Investment Management Group sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 139,976 shares — an estimated $4.1M sold.

Schroder Investment Management Group first reported a position in EVH in Q2 2015 and held it in 18 quarters. The position peaked at $4.63M in Q4 2023. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Schroder Investment Management Group reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 139,976 Evolent Health shares in Q4 2024, an estimated $4.1M.
  • Schroder Investment Management Group first reported a position in Evolent Health in Q2 2015 and held it in 18 quarters.
  • Schroder Investment Management Group's Evolent Health position peaked at $4.63M in Q4 2023.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Schroder Investment Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.